Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] (2021)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; OSORIO, FLAVIA DE LIMA - FMRP ; CAMPOS, ALLINE CRISTINA DE - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; PACHECO, JÚLIA COZAR - FMRP ; SOUZA, JOSÉ DIOGO DOS SANTOS - FMRP
- Unidade: FMRP
- DOI: 10.1097/JCP.0000000000001405
- Subjects: CANABINOIDES; ANTICONVULSIVANTES; COVID-19; ESTRESSE PROFISSIONAL; SAÚDE MENTAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2021
- Source:
- Título: Journal of Clinical Psychopharmacology
- ISSN: 0271-0749
- Volume/Número/Paginação/Ano: v. 41, n. 3, p. 327-329, 2021
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
PACHECO, Júlia Cozar et al. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/JCP.0000000000001405. Acesso em: 10 maio 2026. , 2021 -
APA
Pacheco, J. C., Souza, J. D. dos S., Hallak, J. E. C., Osório, F. de L., Campos, A. C. de, Guimarães, F. S., et al. (2021). Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta]. Journal of Clinical Psychopharmacology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1097/JCP.0000000000001405 -
NLM
Pacheco JC, Souza JD dos S, Hallak JEC, Osório F de L, Campos AC de, Guimarães FS, Zuardi AW, Crippa JA de S. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 327-329.[citado 2026 maio 10 ] Available from: https://doi.org/10.1097/JCP.0000000000001405 -
Vancouver
Pacheco JC, Souza JD dos S, Hallak JEC, Osório F de L, Campos AC de, Guimarães FS, Zuardi AW, Crippa JA de S. Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta] [Internet]. Journal of Clinical Psychopharmacology. 2021 ; 41( 3): 327-329.[citado 2026 maio 10 ] Available from: https://doi.org/10.1097/JCP.0000000000001405 - Case report: cannabidiol-induced skin rash: a case series and key recommendations
- The anxiolytic effects of cannabidiol (CBD)
- Cannabinoids for the treatment of mental disorders [Carta]
- Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022)
- Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes
- Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
- Research and clinical practice involving the use of cannabis products, with emphasis on cannabidiol: a narrative review
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Effects of minocycline on regional cerebral blood flow in schizophrenia
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
